Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrimidooxazocine derivatives as mTOR-inhibitors

Pyrimidooxazocine derivatives as mTOR-inhibitors

US Patent 9120812 · Granted Sep 1, 2015

Estimated economic value: $27,116,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused pentacyclic imidazole derivatives2024
2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido2023
2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido2023
Ethynyl compounds, their preparation and their therapeutic use for the treatment2021
Fused pentacyclic imidazole derivatives as modulators of TNF activity2021
Fused pentacyclic imidazole derivatives2021
2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido2019
2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido2019
Fused pentacyclic imidazole derivatives2019
Oxindole derivatives, preparation thereof and therapeutic use in the treatment o2018
2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF recept2017
Pyrimidinone derivatives as antimalarial agents2016